Results 271 to 280 of about 675,123 (288)

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs

, 2013
E. Wolin, B. Jarzab, B. Eriksson, T. Walter, C. Toumpanakis, M. Morse, P. Tomassetti, M. Weber, D. Fogelman, J. Ramage, D. Poon, Jerry M. Huang, M. Hudson, Jiang Li, J. Pasieka, A. Mahamat, Fredrik Swahn, J. Newell-Price, Wasat Mansoor, K. Öberg   +19 more
semanticscholar   +1 more source

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

Managing Acromegaly With Somatostatin Analogs

The Endocrinologist, 2006
David M. Cook, Marie B. Cook
openaire   +1 more source

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Asymptomatic Thyrotropin-Secreting Pituitary Macroadenoma in a 13-Year-Old Girl: Successful First-Line Treatment with Somatostatin Analogs

Thyroid, 2012
Sarah Rabbiosi, E. Peroni, G. Tronconi, G. Chiumello, M. Losa, G. Weber   +5 more
semanticscholar   +1 more source

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Radioguided Surgery in Neuroendocrine Tumors Using Ga-68-Labeled Somatostatin Analogs: A Pilot Study

Clinical Nuclear Medicine, 2012
D. Kaemmerer, V. Prasad, W. Daffner, S. Haugvik, S. Senftleben, R. Baum, M. Hommann   +6 more
semanticscholar   +1 more source

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly  

Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs

Journal of Endocrinological Investigation, 2012
L. E. Wildemberg, L. V. Neto, D. Costa, L. Nasciuti, C. Takiya, L. M. Alves, A. Rebora, F. Minuto, D. Ferone, M. Gadelha   +9 more
semanticscholar   +1 more source